At Octapharma, we are committed to better understanding von Willebrand disease and to improving the care of people with this condition.
Over 15 years of clinical and real-life experience have already proven the efficacy and tolerability of wilate® in people with all types of von Willebrand disease for surgery, prophylaxis and on-demand treatment.1-3 However, there is still more to learn. We continue to work with the scientific and clinical community to improve our understanding of von Willebrand disease, and are proud to support numerous clinical trials and investigator-initiated studies.
As part of Octapharma’s long-standing commitment to addressing the unmet clinical needs of people with von Willebrand disease, Octapharma continues to carry out clinical trials to better understand the clinical efficacy and safety of wilate® in different patient populations
Link to the trial on clinicaltrials.gov
The von Willebrand factor in pregnancy (VIP) study is a prospective, multicentre, investigator-initiated study aiming to increase our understanding of postpartum bleeding in women with von Willebrand disease.
For more details, visit vipstudy.com or clinicaltrials.gov
A multi-cEntre pilot crossover trial of prophylactic wilate® coMpared to PlacebO for heavy menstrual bleeding in patients with low von WillEbrand factoR and von Willebrand disease (EMPOWER)
The information on this website is not country specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Octapharma representative for the latest information specific to your country.
Please contact your local Octapharma representative for local prescribing information via our contact form.
IMPORTANT
The information on this website is based on the European Summary of Product Characteristics (EU SmPC). US HCPs and other country-specific websites: Below is a list of countries that host a local wilate® website based on local approved information and in local language. Click on the country link to be redirected to the local wilate® website.
The website is provided by Octapharma AG, Seidenstrasse 2, 8853 Lachen, Switzerland
www.octapharma.com
© 2024 Octapharma AG